Project Grant R35GM153268
- This $1,228,250 National Science Foundation project grant supports research into the B chromosome of maize and its impact on genomic processes. Led by the University of Missouri System, the three-year award aims to advance understanding of properties that have allowed the extra, non-essential B chromosome to persist in maize for millions of years despite providing no benefit to the plant. The interdisciplinary team will conduct genetic and molecular analysis to learn the nature of properties...
- This Project Grant award from the National Science Foundation's Biological Sciences program (CFDA 47.074) provides $350,000 to the University of Iowa to support research on the mechanisms involved in the propagation of chromosome fragments in the germline. The 3-year project aims to investigate how DNA breaks that occur during the formation of egg and sperm cells are stabilized and passed on to the next generation. The research will be conducted using the model organism C. elegans and will...
- This $999,999 Project Grant from the National Science Foundation's Biological Sciences program (CFDA 47.074) will fund research at the Donald Danforth Plant Science Center to elucidate the mechanisms initiating de novo chromatin modification cycles in plant cells. Over three years, the award will support experiments using cutting-edge techniques to dissect the molecular triggers establishing heritable DNA methylation patterns and long-term epigenetic silencing of transposable elements and...
- The National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) awarded a $3,201,530 Project Grant to the Sloan-Kettering Institute for Cancer Research to investigate the mechanisms underlying extrachromosomal DNA (ecDNA) segregation and repair in cancer. The key focus areas include: Exploring how the circular topology of ecDNA affects its function and maintenance, specifically examining the RNA-dependent physical tethering of ecDNA to mitotic chromosomes that facilitates...
- This Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower program) provides $144,981 to the University of California, San Diego (UC San Diego) to characterize the role of extrachromosomal DNA (ecDNA) in shaping the heterogeneity and plasticity of glioblastoma (GBM) cellular states. The award period runs from September 3, 2025 to August 31, 2027. The project aims to determine how ecDNA, which are large circular DNA elements harboring oncogenes,...
- This Project Grant award of $460,625.00 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) will support a 5-year research project at the University of Massachusetts Medical School (UMASS Medical) to investigate the phenotypic consequences of aneuploidy, or abnormal chromosome numbers, across different tissues. The key objectives are to: 1) systematically evaluate the fitness impacts of chromosomal copy...
- This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports research by the Stowers Institute for Medical Research to investigate the impact of natural variation in human centromeric DNA sequences and epigenetic patterns on chromosome segregation and genome integrity. The $125,619 grant, awarded on August 1, 2025, will fund research over a 5-year period to map centromeric DNA landscapes and associated kinetochore proteins...
- This Project Grant award from the National Science Foundation's Biological Sciences program (CFDA 47.074) provides $495,594.00 to the University of California, Santa Barbara to conduct research on the mechanisms underlying DNA double-strand break repair through homologous recombination. The objectives of this 5-year project are to 1) define the steps in recombination altered by DNA interstrand crosslinks, 2) explore how the DNA repair regulatory kinase ATR is activated during double-strand break...
- This Project Grant award from the National Science Foundation (NSF) Division of Molecular and Cellular Biosciences, under the Biological Sciences program (CFDA 47.074), provides $910,000 over 4 years to Weill Medical College of Cornell University to conduct research on the regulation of DNA repair mechanisms and transcription at telomeres. The research aims to improve understanding of how genetic information is protected at chromosome ends, which is critical for cell and organism health. The...
- This $119,922 federal Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) supports research by The University of Texas Southwestern Medical Center, doing business as Southwestern Medical School, to dissect the role of the Fanconi Anemia (FA) pathway in driving chromothripsis, a complex chromosomal abnormality observed in approximately 30% of cancer genomes. The research aims to elucidate the underlying mechanisms by which the FA genome maintenance...
EPIGENOMIC CONSEQUENCES OF BREAKAGE-FUSION-BRIDGE CYCLING - PROJECT SUMMARY CHROMOSOME BREAKAGE CAN GENERATE EXTRAORDINARY GENETIC NOVELTY THAT IS SELECTED UPON DURING TUMOR PROGRESSION. ONE COMMONLY OBSERVED FEATURE OF CANCER IS THE BREAKAGE-FUSION-BRIDGE (BFB) CYCLE, WHERE DOUBLE-STRAND BREAKS SET OFF A CHAIN REACTION THAT LEADS TO COPY NUMBER VARIATIONS AND COMPLEX CHROMOSOME SHATTERING EVENTS. THE BFB CYCLE WAS FIRST DESCRIBED IN MAIZE BY BARBARA MCCLINTOCK IN THE 1940S, AND LED TO THE DISCOVERY OF TRANSPOSABLE ELEMENTS (TES). TWO TYPES OF TES, ACTIVATOR/DISSOCIATION (AC/DS) AND SUPPRESSOR-MUTATOR (EN/SPM), BURST FROM HER BFB SAMPLES, LEADING HER TO HYPOTHESIZE THAT CHROMOSOME BREAKAGE CAN LEAD TO A GENOME-WIDE RESPONSE SHE CALLED "GENOME SHOCK". HER OBSERVATION THAT BFB ACTIVATES PREVIOUSLY DORMANT TRANSPOSABLE ELEMENTS SUGGESTS THAT MAJOR EPIGENETIC CHANGES ACCOMPANY BFB, LIKELY COMPROMISING DNA METHYLATION AND HETEROCHROMATIN. DNA DEMETHYLATION AND TE ACTIVATION ARE ALSO OBSERVED IN MANY CANCERS, BUT CAUSAL RELATIONSHIPS BETWEEN BFB AND DEMETHYLATION HAVE NOT BEEN CLEARLY ESTABLISHED. UNLIKE IN ANIMALS, MAIZE TOLERATES THE TRANSMISSION OF MAJOR CHROMOSOMAL ABNORMALITIES THROUGH GAMETOGENESIS, GREATLY FACILITATING DOWNSTREAM STUDIES. WE HAVE DEVELOPED A SYSTEM FOR INDUCING THE BFB CYCLE IN MAIZE AND DEMONSTRATED ITS ABILITY TO INDUCE GENETIC INSTABILITY AND LARGE CHROMOSOMAL ABNORMALITIES. IN OUR APPROACH, AN ARRAY OF LEXO REPEATS INSERTED ON A CHROMOSOME ARM IS COMBINED WITH A LEXA- CENH3 TRANSGENE AND INITIATES A SECOND CENTROMERE. WITH LONG READ SEQUENCING AND CHIP-SEQ ASSAYS, WE WILL ANALYZE THE GENOMIC AND EPIGENOMIC CHANGES THAT FOLLOW BFB OVER MULTIPLE GENERATIONS. WE WILL ALSO DEPLOY HIGH-SENSITIVITY SCREENS FOR TE ACTIVATION. THESE APPROACHES WILL ALLOW US TO TEST AT THE MOLECULAR LEVEL THE EXTENT TO WHICH GENOME REORDERING BY BFB LEADS TO GENETIC AND EPIGENETIC CHANGES IN OTHERWISE WILD TYPE GENETIC BACKGROUNDS. THE PROPOSED RESEARCH WILL ESTABLISH A NEW MODEL FOR INVESTIGATING BFB IN COMPLEX EUKARYOTES AND PROVIDE GREATER INSIGHT INTO HOW THE BFB CYCLE IMPACTS EPIGENETIC PROCESSES THAT HAVE THE POTENTIAL TO FURTHER DESTABILIZE THE GENOME. IN ADDITION, THE WORK WILL PROVIDE A DIRECT TEST OF THE GENOME SHOCK HYPOTHESIS, WHICH HAS PROVIDED AN IMPORTANT GUIDEPOST FOR INTERPRETING THE CHROMOSOME REARRANGEMENTS IN CANCER AS WELL AS HUNDREDS OF OTHER GENOME RESTRUCTURING EVENTS IN ANIMALS, PLANTS, AND FUNGI.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $368.4k | 5/26/25 | ||
| Not listed | $0 | 11/7/24 | ||
| Not listed | $0 | 11/7/24 | ||
| Not listed | $376.0k | 7/29/24 | ||
| Not listed | $376.0k | 7/29/24 |